In the global hunt for coronavirus treatments, a Japanese antiviral medicine known as Avigan has won plaudits from Prime Minister Shinzo Abe and $128 million in government funding.
But it's not the only game in town.
Camostat, a 35-year old pancreatitis drug made by Osaka-based Ono Pharmaceutical Co., has captured the interest of scientists in Japan and overseas with little fanfare or state assistance.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.